Page last updated: 2024-08-07 17:02:42

Peroxisome proliferator-activated receptor alpha

A peroxisome proliferator-activated receptor alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q07869]

Synonyms

PPAR-alpha;
Nuclear receptor subfamily 1 group C member 1

Research

Bioassay Publications (186)

TimeframeStudies on this Protein(%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (2.69)18.2507
2000's87 (46.77)29.6817
2010's79 (42.47)24.3611
2020's15 (8.06)2.80

Compounds (124)

Drugs with Potency Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
palmitic acidHomo sapiens (human)Potency17.782810
2,4,6-tribromophenolHomo sapiens (human)Potency37.646010
N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamideHomo sapiens (human)Potency8.912510
bithionolHomo sapiens (human)Potency26.651410
ciglitazoneHomo sapiens (human)Potency44.668410
ciprofibrateHomo sapiens (human)Potency14.125410
dichlorophenHomo sapiens (human)Potency39.810710
endosulfanHomo sapiens (human)Potency44.668410
flufenamic acidHomo sapiens (human)Potency28.183810
gossypolHomo sapiens (human)Potency15.848910
mefenamic acidHomo sapiens (human)Potency35.481310
mitotaneHomo sapiens (human)Potency39.810710
chlordanHomo sapiens (human)Potency31.622810
2,3,4,6-tetrachlorophenolHomo sapiens (human)Potency44.668410
dichlorodiphenyldichloroethaneHomo sapiens (human)Potency50.118710
1-naphthylphenylamineHomo sapiens (human)Potency50.118710
2-phenylphenolHomo sapiens (human)Potency251.189010
4,4'-thiobis(6-tert-butyl-3-cresol)Homo sapiens (human)Potency7.843510
trans-4-tert-butylcyclohexanolHomo sapiens (human)Potency1.122010
12-hydroxy stearic acidHomo sapiens (human)Potency31.622810
dicofolHomo sapiens (human)Potency31.622810
2,2'-methylenebis(4-methyl-6-tert-butylphenol)Homo sapiens (human)Potency14.125410
2-Phenylethyl 2-aminobenzoateHomo sapiens (human)Potency2.511910
4-tert-octylphenolHomo sapiens (human)Potency25.118910
myristic acidHomo sapiens (human)Potency33.527810
allethrinsHomo sapiens (human)Potency50.118710
o,p'-ddtHomo sapiens (human)Potency50.118710
heptachlor epoxideHomo sapiens (human)Potency50.118710
antimycin aHomo sapiens (human)Potency35.481310
ioxynilHomo sapiens (human)Potency15.848910
bromoxynilHomo sapiens (human)Potency25.118910
bromoxynil octanoateHomo sapiens (human)Potency44.668410
(2-hydroxy-4-(octyloxy)phenyl)phenylmethanoneHomo sapiens (human)Potency44.668410
4-(octyloxy)benzoic acidHomo sapiens (human)Potency7.079510
gamma-glycidoxypropyltrimethoxysilaneHomo sapiens (human)Potency39.810710
bromotriethylstannaneHomo sapiens (human)Potency5.011910
mono-(2-ethylhexyl)phthalateHomo sapiens (human)Potency31.832610
isostearateHomo sapiens (human)Potency39.810710
isopropyl 4,4'-dibromobenzilateHomo sapiens (human)Potency31.622810
butylated hydroxytolueneHomo sapiens (human)Potency39.810710
amitrazHomo sapiens (human)Potency39.810710
oxyfluorofenHomo sapiens (human)Potency50.118710
dichlorfop-methylHomo sapiens (human)Potency44.668410
imazethapyrHomo sapiens (human)Potency39.810710
lactofenHomo sapiens (human)Potency35.481310
1-(diiodomethyl)sulfonyl-4-methyl benzeneHomo sapiens (human)Potency28.183810
perfluorooctanesulfonamideHomo sapiens (human)Potency44.668410
2-bromopalmitateHomo sapiens (human)Potency14.125410
4-chloro-n-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1h-pyrazole-5-carboxamideHomo sapiens (human)Potency39.810710
1-(carboxymethylthio)tetradecaneHomo sapiens (human)Potency10.000010
lanosterolHomo sapiens (human)Potency12.589310
oleic acidHomo sapiens (human)Potency35.481310
tamoxifen citrateHomo sapiens (human)Potency50.118710
azoxystrobinHomo sapiens (human)Potency19.952610
gw 7647Homo sapiens (human)Potency0.015810
sodium dodecyl sulfateHomo sapiens (human)Potency44.668410
linoleic acidHomo sapiens (human)Potency36.426110
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acidHomo sapiens (human)Potency44.668410
methylbenzethonium chlorideHomo sapiens (human)Potency25.118910
l-165041Homo sapiens (human)Potency11.220210
6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde o-(3,4-dichlorobenzyl)oximeHomo sapiens (human)Potency35.481310
sorbitan monooleateHomo sapiens (human)Potency39.810710
gw0742Homo sapiens (human)Potency1.995310
mesosulfuron-methylHomo sapiens (human)Potency35.481310
sarkosylHomo sapiens (human)Potency39.810710
docusate sodiumHomo sapiens (human)Potency50.118710

Drugs with Inhibition Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
bisindolylmaleimide iHomo sapiens (human)IC500.006016
fenofibrateHomo sapiens (human)IC501.000011
pioglitazoneHomo sapiens (human)IC5010.000011
pirinixic acidHomo sapiens (human)IC5023.205022
pirinixic acidHomo sapiens (human)Ki4.315022
fenofibric acidHomo sapiens (human)IC5034.125088
fenofibric acidHomo sapiens (human)Ki35.000011
telmisartanHomo sapiens (human)IC5010.000011
rosiglitazoneHomo sapiens (human)IC5026.38921818
rosiglitazoneHomo sapiens (human)Ki33.300011
mk 767Homo sapiens (human)IC500.914011
mk 767Homo sapiens (human)Ki0.230011
farglitazarHomo sapiens (human)IC502.043522
farglitazarHomo sapiens (human)Ki0.489922
muraglitazarHomo sapiens (human)IC500.220022
tesaglitazarHomo sapiens (human)IC503.800011
tesaglitazarHomo sapiens (human)Ki1.000011
gw 409544Homo sapiens (human)Ki0.002011
gw 6471Homo sapiens (human)IC500.240011
drf 2725Homo sapiens (human)IC500.980011
drf 2725Homo sapiens (human)Ki0.980011
gsk 3787Homo sapiens (human)IC5010.000011
gw 7647Homo sapiens (human)IC500.000511
gw 7647Homo sapiens (human)Ki0.004644
pregna-4,17-diene-3,16-dioneHomo sapiens (human)IC5020.000011
amorphastilbolHomo sapiens (human)IC501.520011
gw 501516Homo sapiens (human)IC502.108467
tzd 18Homo sapiens (human)IC500.028022
tzd 18Homo sapiens (human)Ki0.030011
gw 9578Homo sapiens (human)IC500.120011
gw 7845Homo sapiens (human)Ki1.100011
naveglitazarHomo sapiens (human)IC502.710622
ly 465608Homo sapiens (human)IC500.174011
ly 465608Homo sapiens (human)Ki0.170011
l 796449Homo sapiens (human)IC500.054022
3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acidHomo sapiens (human)IC500.287534
bm 131246Homo sapiens (human)IC504.086011
aleglitazarHomo sapiens (human)IC500.038011
sotrastaurinHomo sapiens (human)IC500.003116
gw9508Homo sapiens (human)Ki3.162311
bms 687453Homo sapiens (human)IC500.260022
ys 121Homo sapiens (human)IC501.000011
10-nitro-oleic acidHomo sapiens (human)IC5015.000011
gsk0660Homo sapiens (human)IC5010.000011
ly 518674Homo sapiens (human)IC500.024022

Drugs with Activation Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
palmitic acidHomo sapiens (human)EC5035.000011
gw 2433Homo sapiens (human)EC500.170011
ciprofibrateHomo sapiens (human)EC500.900022
clofibrateHomo sapiens (human)EC5055.000033
clofibric acidHomo sapiens (human)EC5052.177899
decanoic acidHomo sapiens (human)EC5031.000011
fenofibrateHomo sapiens (human)EC5029.43501212
gemfibrozilHomo sapiens (human)EC50114.350044
pioglitazoneHomo sapiens (human)EC506.686733
stearic acidHomo sapiens (human)EC5040.000011
pirinixic acidHomo sapiens (human)EC508.92693738
pirinixic acidHomo sapiens (human)Kd0.018911
methyleugenolHomo sapiens (human)EC5046.500011
myristic acidHomo sapiens (human)EC5013.000011
bezafibrateHomo sapiens (human)EC5044.53711414
fenofibric acidHomo sapiens (human)EC5024.17871919
ursolic acidHomo sapiens (human)EC5041.310011
telmisartanHomo sapiens (human)EC5010.000011
rosiglitazoneHomo sapiens (human)EC506.77684040
mk 767Homo sapiens (human)EC500.871588
mk 767Homo sapiens (human)Kd0.229022
jtt 501Homo sapiens (human)EC501.900022
anacardic acidHomo sapiens (human)EC503.500011
farglitazarHomo sapiens (human)EC500.371777
muraglitazarHomo sapiens (human)EC500.952899
tesaglitazarHomo sapiens (human)EC503.21161112
oleic acidHomo sapiens (human)EC5036.000011
gw 409544Homo sapiens (human)EC500.051355
drf 2725Homo sapiens (human)EC503.136766
epipinoresinolHomo sapiens (human)EC5060.000011
gw 7647Homo sapiens (human)EC500.61693838
gw 7647Homo sapiens (human)Kd32.144533
psi-baptigeninHomo sapiens (human)EC508.900033
n-oleoylethanolamineHomo sapiens (human)EC500.143855
pregna-4,17-diene-3,16-dioneHomo sapiens (human)EC50100.000011
amorphastilbolHomo sapiens (human)EC5012.000011
gw 1929Homo sapiens (human)EC5055.300011
l-165041Homo sapiens (human)EC505.488522
alpha-glutamyltryptophanHomo sapiens (human)EC5083.400011
alpha-glutamyltryptophanHomo sapiens (human)Kd120.000011
gw 501516Homo sapiens (human)EC502.72901924
tzd 18Homo sapiens (human)EC500.027333
gft505Homo sapiens (human)EC500.438155
gw 9578Homo sapiens (human)EC500.14521010
gw 7845Homo sapiens (human)EC503.500022
naveglitazarHomo sapiens (human)EC502.808022
ly 465608Homo sapiens (human)EC500.149833
l 796449Homo sapiens (human)EC500.011022
gw0742Homo sapiens (human)EC501.506733
3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acidHomo sapiens (human)EC500.125011
ns-220Homo sapiens (human)EC502.354033
bm 131246Homo sapiens (human)EC500.771011
gw 590735Homo sapiens (human)EC501.1725911
gw 590735Homo sapiens (human)Kd0.170011
aleglitazarHomo sapiens (human)EC500.050011
mbx-8025Homo sapiens (human)EC501.250022
lt175Homo sapiens (human)EC500.2661810
bms 687453Homo sapiens (human)EC500.022233
amorfrutin aHomo sapiens (human)Kd27.000011
amorfrutin bHomo sapiens (human)Kd2.600011
ys 121Homo sapiens (human)EC501.000011
ly 518674Homo sapiens (human)EC500.042033

Drugs with Other Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
troglitazoneHomo sapiens (human)Fold activation1.120011
farglitazarHomo sapiens (human)Log Ki6.310011
gw 1929Homo sapiens (human)Log Ki5.500011

Enables

This protein enables 23 target(s):

TargetCategoryDefinition
RNA polymerase II cis-regulatory region sequence-specific DNA bindingmolecular functionBinding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. [GOC:txnOH-2018]
DNA-binding transcription factor activity, RNA polymerase II-specificmolecular functionA DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. [GOC:txnOH-2018]
DNA-binding transcription activator activitymolecular functionA DNA-binding transcription factor activity that activates or increases transcription of specific gene sets. [GOC:txnOH-2018]
transcription coactivator bindingmolecular functionBinding to a transcription coactivator, a protein involved in positive regulation of transcription via protein-protein interactions with transcription factors and other proteins that positively regulate transcription. Transcription coactivators do not bind DNA directly, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. [GOC:krc]
DNA-binding transcription repressor activity, RNA polymerase II-specificmolecular functionA DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II. [GOC:txnOH-2018]
DNA-binding transcription activator activity, RNA polymerase II-specificmolecular functionA DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II. [GOC:aruk, GOC:txnOH-2018, PMID:20737563, PMID:27145859]
DNA bindingmolecular functionAny molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). [GOC:dph, GOC:jl, GOC:tb, GOC:vw]
DNA-binding transcription factor activitymolecular functionA transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. [GOC:txnOH-2018]
nuclear steroid receptor activitymolecular functionCombining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function. [GOC:signaling, PMID:14708019]
nuclear receptor activitymolecular functionA DNA-binding transcription factor activity regulated by binding to a ligand that modulates the transcription of specific gene sets transcribed by RNA polymerase II. Nuclear receptor ligands are usually lipid-based (such as a steroid hormone) and the binding of the ligand to its receptor often occurs in the cytosol, which leads to its translocation to the nucleus. [GOC:txnOH-2018, PMID:23457262]
protein bindingmolecular functionBinding to a protein. [GOC:go_curators]
zinc ion bindingmolecular functionBinding to a zinc ion (Zn). [GOC:ai]
lipid bindingmolecular functionBinding to a lipid. [GOC:ai]
phosphatase bindingmolecular functionBinding to a phosphatase. [GOC:jl]
protein domain specific bindingmolecular functionBinding to a specific domain of a protein. [GOC:go_curators]
mitogen-activated protein kinase kinase kinase bindingmolecular functionBinding to a mitogen-activated protein kinase kinase kinase, a protein that can phosphorylate a MAP kinase kinase. [GOC:bf]
ubiquitin conjugating enzyme bindingmolecular functionBinding to a ubiquitin conjugating enzyme, any of the E2 proteins. [GOC:vp]
sequence-specific DNA bindingmolecular functionBinding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. [GOC:jl]
protein-containing complex bindingmolecular functionBinding to a macromolecular complex. [GOC:jl]
NFAT protein bindingmolecular functionBinding to NFAT (nuclear factor of activated T cells) proteins, a family of transcription factors. NFAT proteins have crucial roles in the development and function of the immune system. [PMID:15928679]
RNA polymerase II-specific DNA-binding transcription factor bindingmolecular functionBinding to a sequence-specific DNA binding RNA polymerase II transcription factor, any of the factors that interact selectively and non-covalently with a specific DNA sequence in order to modulate transcription. [GOC:dph, GOC:vw]
MDM2/MDM4 family protein bindingmolecular functionBinding to a member of the MDM2/MDM4 protein family, comprising negative regulators of p53. [InterPro:IPR016495]
DNA-binding transcription factor bindingmolecular functionBinding to a DNA-binding transcription factor, a protein that interacts with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. [GOC:txnOH-2018]

Located In

This protein is located in 2 target(s):

TargetCategoryDefinition
nucleuscellular componentA membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators]
nucleoplasmcellular componentThat part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653]

Active In

This protein is active in 1 target(s):

TargetCategoryDefinition
nucleuscellular componentA membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators]

Part Of

This protein is part of 1 target(s):

TargetCategoryDefinition
chromatincellular componentThe ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]

Involved In

This protein is involved in 42 target(s):

TargetCategoryDefinition
negative regulation of transcription by RNA polymerase IIbiological processAny process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH]
response to hypoxiabiological processAny process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. [GOC:hjd]
gluconeogenesisbiological processThe formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. [MetaCyc:GLUCONEO-PWY]
heart developmentbiological processThe process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. [GOC:jid, UBERON:0000948]
response to nutrientbiological processAny process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. [GOC:go_curators]
epidermis developmentbiological processThe process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species. [GOC:go_curators, UBERON:0001003]
cellular response to starvationbiological processAny process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment. [GOC:jl]
regulation of cellular ketone metabolic processbiological processAny process that modulates the chemical reactions and pathways involving any of a class of organic compounds that contain the carbonyl group, CO, and in which the carbonyl group is bonded only to carbon atoms. The general formula for a ketone is RCOR, where R and R are alkyl or aryl groups. [GOC:dph, GOC:tb]
negative regulation of macrophage derived foam cell differentiationbiological processAny process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions. [GOC:add, GOC:BHF, GOC:dph, GOC:tb]
negative regulation of cholesterol storagebiological processAny process that decreases the rate or extent of cholesterol storage. Cholesterol storage is the accumulation and maintenance in cells or tissues of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. [GOC:BHF, GOC:dph, GOC:tb]
negative regulation of sequestering of triglyceridebiological processAny process that decreases the rate, frequency or extent of sequestering of triglyceride. Triglyceride sequestration is the process of binding or confining any triester of glycerol such that it is separated from other components of a biological system. [GOC:BHF, GOC:dph, GOC:tb]
regulation of fatty acid metabolic processbiological processAny process that modulates the frequency, rate or extent of the chemical reactions and pathways involving fatty acids. [GOC:go_curators]
intracellular receptor signaling pathwaybiological processThe series of molecular signals initiated by a ligand binding to a receptor located within a cell. [GOC:bf, GOC:mah]
positive regulation of fatty acid beta-oxidationbiological processAny process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation. [GOC:mah]
negative regulation of appetitebiological processAny process that reduces appetite. [GOC:add]
response to insulinbiological processAny process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. [GOC:mah, ISBN:0198506732]
circadian regulation of gene expressionbiological processAny process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours. [GOC:mah]
behavioral response to nicotinebiological processAny process that results in a change in the behavior of an organism as a result of a nicotine stimulus. [GOC:bf, ISBN:0198506732]
wound healingbiological processThe series of events that restore integrity to a damaged tissue, following an injury. [GOC:bf, PMID:15269788]
lipoprotein metabolic processbiological processThe chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids. [ISBN:0198506732]
regulation of circadian rhythmbiological processAny process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours. [GOC:dph, GOC:jl, GOC:tb]
steroid hormone mediated signaling pathwaybiological processThe series of molecular signals mediated by a steroid hormone binding to a receptor. [PMID:12606724]
response to ethanolbiological processAny process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. [GOC:go_curators]
positive regulation of gluconeogenesisbiological processAny process that activates or increases the frequency, rate or extent of gluconeogenesis. [GOC:go_curators]
negative regulation of blood pressurebiological processAny process in which the force of blood traveling through the circulatory system is decreased. [GOC:go_curators, GOC:mtg_cardio]
negative regulation of glycolytic processbiological processAny process that stops, prevents, or reduces the frequency, rate or extent of glycolysis. [GOC:go_curators]
positive regulation of DNA-templated transcriptionbiological processAny process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH]
positive regulation of transcription by RNA polymerase IIbiological processAny process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. [GOC:go_curators, GOC:txnOH]
nitric oxide metabolic processbiological processThe chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. [GOC:ai]
positive regulation of fatty acid oxidationbiological processAny process that activates or increases the frequency, rate or extent of fatty acid oxidation. [GOC:ai]
positive regulation of lipid biosynthetic processbiological processAny process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids. [GOC:ai]
negative regulation of inflammatory responsebiological processAny process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. [GOC:ai]
negative regulation of cell growth involved in cardiac muscle cell developmentbiological processAny process that decreases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state. [GOC:dph]
enamel mineralizationbiological processThe process in which calcium salts, mainly carbonated hydroxyapatite, are deposited in tooth enamel. [GOC:BHF, GOC:mah, GOC:sl, PMID:10206335, PMID:16931858, PMID:21196346]
cellular response to fructose stimulusbiological processAny process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fructose stimulus. [GOC:mah]
negative regulation of miRNA transcriptionbiological processAny process that stops, prevents or reduces the frequency, rate or extent of microRNA (miRNA) gene transcription. [GO_REF:0000058, GOC:dph, GOC:kmv, GOC:TermGenie, PMID:24699545]
negative regulation of leukocyte cell-cell adhesionbiological processAny process that stops, prevents or reduces the frequency, rate or extent of leukocyte cell-cell adhesion. [GO_REF:0000058, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:21106532]
regulation of fatty acid transportbiological processAny process that modulates the frequency, rate or extent of fatty acid transport. [GOC:BHF]
hormone-mediated signaling pathwaybiological processThe series of molecular signals mediated by the detection of a hormone. [GOC:sm]
fatty acid metabolic processbiological processThe chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. [ISBN:0198547684]
positive regulation of fatty acid metabolic processbiological processAny process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving fatty acids. [GOC:go_curators]
cell differentiationbiological processThe cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. [ISBN:0198506732]